-
EP4164677
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4164677
| EP4164677 - PROTEASE COMPOSITION [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 17.03.2023 Database last updated on 12.10.2024 | |
| Former | The international publication has been made Status updated on 24.12.2021 | Most recent event Tooltip | 02.07.2024 | Supplementary search report | published on 31.07.2024 [2024/31] | Applicant(s) | For all designated states Anatara Lifesciences Limited 433 Logan Road Stones Corner Brisbane, QLD 4120 / AU | [2023/16] | Inventor(s) | 01 /
YONGQING, Tang Bayswater, Victoria 3153 / AU | 02 /
WEST, Michael Leo Parkville, Victoria 3052 / AU | [2023/16] | Representative(s) | Ullrich & Naumann PartG mbB Schneidmühlstrasse 21 69115 Heidelberg / DE | [2023/16] | Application number, filing date | 21825115.5 | 15.06.2021 | [2023/16] | WO2021IB55237 | Priority number, date | AU20200901985 | 16.06.2020 Original published format: AU 2020901985 | [2023/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021255625 | Date: | 23.12.2021 | Language: | EN | [2021/51] | Type: | A1 Application with search report | No.: | EP4164677 | Date: | 19.04.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.12.2021 takes the place of the publication of the European patent application. | [2023/16] | Search report(s) | International search report - published on: | AU | 23.12.2021 | (Supplementary) European search report - dispatched on: | EP | 01.07.2024 | Classification | IPC: | A61K38/43, A61K47/12, A61K47/16, A61K47/24, C12N9/96, A61K9/08, A61K9/19, A61K38/48, A61K47/02, C12N9/50, C12N9/52 | [2024/31] | CPC: |
A61K47/12 (EP,AU,US);
C12N9/96 (EP,AU);
A61K38/4873 (EP,AU,US);
A61K36/88 (US);
A61K47/02 (EP,US);
A61K47/16 (AU);
A61K47/183 (US);
A61K47/24 (AU,US);
A61K9/0095 (US);
A61K9/08 (EP);
A61K9/19 (EP,US);
C12N9/52 (EP);
C12N9/63 (EP,AU,US);
C12Y304/22031 (EP,AU,US);
C12Y304/22032 (EP,AU);
C12Y304/22033 (EP,AU)
(-)
|
| Former IPC [2023/16] | A61K38/43, A61K47/12, A61K47/16, A61K47/24, C12N9/96 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/16] | Title | German: | PROTEASEZUSAMMENSETZUNG | [2023/16] | English: | PROTEASE COMPOSITION | [2023/16] | French: | COMPOSITION DE PROTÉASE | [2023/16] | Entry into regional phase | 12.01.2023 | National basic fee paid | 12.01.2023 | Search fee paid | 12.01.2023 | Designation fee(s) paid | 12.01.2023 | Examination fee paid | Examination procedure | 12.01.2023 | Amendment by applicant (claims and/or description) | 12.01.2023 | Examination requested [2023/16] | Fees paid | Renewal fee | 21.06.2023 | Renewal fee patent year 03 | 17.06.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2006054309 (MEDIWOUND LTD [IL], et al); | [Y]WO2013011514 (MEDIWOUND LTD [IL], et al); | International search | [A]EP2173868 (URSAPHARM ARZNEIMITTEL GMBH [DE]); | [A]WO2017031299 (ANATARA LIFESCIENCES LTD [AU], et al); |